| # | Drug | Count |
|---|---|---|
| 0 | CLOPIDOGREL | 12 |
| 1 | ASPIRIN | 11 |
| 2 | ASPIRIN 325 MG | 10 |
| 3 | ASPIRIN 81 MG | 10 |
| 4 | ETANERCEPT | 7 |
| 5 | ETONOGESTREL AND ETHINYL ESTRADIOL | 7 |
| 6 | FUROSEMIDE | 7 |
| 7 | INSULIN GLARGINE | 6 |
| 8 | PANTOPRAZOLE | 6 |
| 9 | PREDNISONE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOTAGLIFLOZIN | 2 | 0.0036 |
| 1 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 2 | DIFLUNISAL | 1 | 0.0012 |
| 3 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 4 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 5 | PHENELZINE SULFATE | 1 | 0.0006 |
| 6 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 7 | BRODALUMAB | 1 | 0.0005 |
| 8 | CLONIDINE TRANSDERMAL SYSTEM | 1 | 0.0005 |
| 9 | PENTOXIFYLLINE | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 12 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 3 | Factor Xa Inhibitor [EPC] | 9 |
| 4 | Corticosteroid [EPC] | 8 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 8 |
| 6 | Insulin Analog [EPC] | 8 |
| 7 | Loop Diuretic [EPC] | 8 |
| 8 | beta-Adrenergic Blocker [EPC] | 8 |
| 9 | Estrogen [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 2 | Anti-anginal [EPC] | 2 | 0.0002 |
| 3 | PCSK9 Inhibitor [EPC] | 4 | 0.0002 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |
| 5 | Glinide [EPC] | 1 | 0.0001 |
| 6 | Nitrate Vasodilator [EPC] | 7 | 0.0001 |
| 7 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Muscle Relaxant [EPC] | 2 | 0.0000 |
| 9 | Insulin [EPC] | 2 | 0.0000 |